FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200361357> ?p ?o ?g. }

• W4200361357 endingPage "2512" @default.
• W4200361357 startingPage "2512" @default.
• W4200361357 abstract "Typhoid fever is caused by a pathogenic, rod-shaped, flagellated, and Gram-negative bacterium known as Salmonella Typhi. It features a polysaccharide capsule that acts as a virulence factor and deceives the host immune system by protecting phagocytosis. Typhoid fever remains a major health concern in low and middle-income countries, with an estimated death rate of ~200,000 per annum. However, the situation is exacerbated by the emergence of the extensively drug-resistant (XDR) strain designated as H58 of S. Typhi. The emergence of the XDR strain is alarming, and it poses serious threats to public health due to the failure of the current therapeutic regimen. A relatively newer computational method called subtractive genomics analyses has been widely applied to discover novel and new drug targets against pathogens, particularly drug-resistant ones. The method involves the gradual reduction of the complete proteome of the pathogen, leading to few potential and novel drug targets. Thus, in the current study, a subtractive genomics approach was applied against the Salmonella XDR strain to identify potential drug targets. The current study predicted four prioritized proteins (i.e., Colanic acid biosynthesis acetyltransferase wcaB, Shikimate dehydrogenase aroE, multidrug efflux RND transporter permease subunit MdtC, and pantothenate synthetase panC) as potential drug targets. Though few of the prioritized proteins are treated in the literature as the established drug targets against other pathogenic bacteria, these drug targets are identified here for the first time against S. Typhi (i.e., S. Typhi XDR). The current study aimed at drawing attention to new drug targets against S. Typhi that remain largely unexplored. One of the prioritized drug targets, i.e., Colanic acid biosynthesis acetyltransferase, was predicted as a unique, new drug target against S. Typhi XDR. Therefore, the Colanic acid was further explored using structure-based techniques. Additionally, ~1000 natural compounds were docked with Colanic acid biosynthesis acetyltransferase, resulting in the prediction of seven compounds as potential lead candidates against the S. Typhi XDR strain. The ADMET properties and binding energies via the docking program of these seven compounds characterized them as novel drug candidates. They may potentially be used for the development of future drugs in the treatment of Typhoid fever." @default.
• W4200361357 created "2021-12-31" @default.
• W4200361357 creator A5005865470 @default.
• W4200361357 creator A5024072502 @default.
• W4200361357 creator A5029482459 @default.
• W4200361357 creator A5040940511 @default.
• W4200361357 creator A5047047937 @default.
• W4200361357 creator A5060711131 @default.
• W4200361357 creator A5063716977 @default.
• W4200361357 creator A5085398326 @default.
• W4200361357 date "2021-12-03" @default.
• W4200361357 modified "2023-09-25" @default.
• W4200361357 title "Identification of a Novel Therapeutic Target against XDR Salmonella Typhi H58 Using Genomics Driven Approach Followed Up by Natural Products Virtual Screening" @default.
• W4200361357 cites W1500947944 @default.
• W4200361357 cites W1606564717 @default.
• W4200361357 cites W1803102843 @default.
• W4200361357 cites W1972770043 @default.
• W4200361357 cites W1975447903 @default.
• W4200361357 cites W1988710574 @default.
• W4200361357 cites W1992182240 @default.
• W4200361357 cites W1994112494 @default.
• W4200361357 cites W2026937656 @default.
• W4200361357 cites W2053096433 @default.
• W4200361357 cites W2071552326 @default.
• W4200361357 cites W2073735874 @default.
• W4200361357 cites W2075578689 @default.
• W4200361357 cites W2079937125 @default.
• W4200361357 cites W2106857639 @default.
• W4200361357 cites W2115135671 @default.
• W4200361357 cites W2131966442 @default.
• W4200361357 cites W2140000393 @default.
• W4200361357 cites W2141474275 @default.
• W4200361357 cites W2149434585 @default.
• W4200361357 cites W2149938180 @default.
• W4200361357 cites W2156125289 @default.
• W4200361357 cites W2156345326 @default.
• W4200361357 cites W2160382463 @default.
• W4200361357 cites W2162792752 @default.
• W4200361357 cites W2162914927 @default.
• W4200361357 cites W2277726492 @default.
• W4200361357 cites W2399060478 @default.
• W4200361357 cites W2406531951 @default.
• W4200361357 cites W2568731469 @default.
• W4200361357 cites W2588309452 @default.
• W4200361357 cites W2767891136 @default.
• W4200361357 cites W2788800189 @default.
• W4200361357 cites W2789848679 @default.
• W4200361357 cites W2792920971 @default.
• W4200361357 cites W2807137981 @default.
• W4200361357 cites W2888270285 @default.
• W4200361357 cites W2900569176 @default.
• W4200361357 cites W2901661869 @default.
• W4200361357 cites W2903383142 @default.
• W4200361357 cites W2920590876 @default.
• W4200361357 cites W2921824535 @default.
• W4200361357 cites W2940788325 @default.
• W4200361357 cites W2954396852 @default.
• W4200361357 cites W2965753825 @default.
• W4200361357 cites W2999673211 @default.
• W4200361357 cites W3000297642 @default.
• W4200361357 cites W3092054514 @default.
• W4200361357 cites W3104537585 @default.
• W4200361357 cites W3134702952 @default.
• W4200361357 cites W3149307439 @default.
• W4200361357 doi "https://doi.org/10.3390/microorganisms9122512" @default.
• W4200361357 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34946114" @default.
• W4200361357 hasPublicationYear "2021" @default.
• W4200361357 type Work @default.
• W4200361357 citedByCount "8" @default.
• W4200361357 countsByYear W42003613572022 @default.
• W4200361357 countsByYear W42003613572023 @default.
• W4200361357 crossrefType "journal-article" @default.
• W4200361357 hasAuthorship W4200361357A5005865470 @default.
• W4200361357 hasAuthorship W4200361357A5024072502 @default.
• W4200361357 hasAuthorship W4200361357A5029482459 @default.
• W4200361357 hasAuthorship W4200361357A5040940511 @default.
• W4200361357 hasAuthorship W4200361357A5047047937 @default.
• W4200361357 hasAuthorship W4200361357A5060711131 @default.
• W4200361357 hasAuthorship W4200361357A5063716977 @default.
• W4200361357 hasAuthorship W4200361357A5085398326 @default.
• W4200361357 hasBestOaLocation W42003613571 @default.
• W4200361357 hasConcept C104317684 @default.
• W4200361357 hasConcept C149011108 @default.
• W4200361357 hasConcept C190114821 @default.
• W4200361357 hasConcept C2780035454 @default.
• W4200361357 hasConcept C2994552716 @default.
• W4200361357 hasConcept C520601542 @default.
• W4200361357 hasConcept C54355233 @default.
• W4200361357 hasConcept C547475151 @default.
• W4200361357 hasConcept C60644358 @default.
• W4200361357 hasConcept C74187038 @default.
• W4200361357 hasConcept C86803240 @default.
• W4200361357 hasConcept C89423630 @default.
• W4200361357 hasConcept C98274493 @default.
• W4200361357 hasConceptScore W4200361357C104317684 @default.
• W4200361357 hasConceptScore W4200361357C149011108 @default.
• W4200361357 hasConceptScore W4200361357C190114821 @default.
• W4200361357 hasConceptScore W4200361357C2780035454 @default.

• next